Original paper<br>Dynamics of anti-CCP antibodies and COMP level in sera of RA patients treated with leflunomide

Jakub Ząbek; Maria Rell-Bakalarska; Lidia Rutkowska-Sak; Janusz Jaworski; Bożena Wojciechowska

eISSN: 2084-9834
ISSN: 0034-6233

Reumatologia/Rheumatology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

6/2007
vol. 45

Send email

Copy url:

abstract:

Original paper
Dynamics of anti-CCP antibodies and COMP level in sera of RA patients treated with leflunomide

Jakub Ząbek

,

Maria Rell-Bakalarska

,

Lidia Rutkowska-Sak

,

Janusz Jaworski

,

Bożena Wojciechowska

Reumatologia 2007; 45, 6: 325–330

Online publish date: 2007/12/20

View full text Get citation

The usefulness of newly introduced laboratory parameters such as anti-CCP antibody level (specific „marker” autoantibody in RA) and cartilage oligomeric matrix protein (COMP) level (a very sensitive marker of cartilage degradation), in comparison with RF-IgM level, laboratory disease parameters (ESR, CRP, RBC, Hb and platelet count) and selected clinical parameters (morning stiffness, count of swollen and painful joints, VAS and DAS-28 score) were analyzed in a group of 34 (randomly selected) leflunomide (LFM) treated RA patients – formerly unsuccessfully treated with two DMARD-s (also with methotrexate).
Significant differences in ESR rate and platelet count, and also in the case of morning stiffness, count of swollen and painful joints, VAS and DAS-28 scores between the group of LFM treated and untreated were observed. Between analyzed serological parameters such as RF-IgM and anti-CCP antibody level no significant differences between groups (untreated vs LFM treated) were found.
Of note, a statistically significant decrease in COMP level, correlated with improvement of the above analyzed clinical parameters, is observed.

keywords:

rheumatoid arthritis, leflunomid, anti-CCP antibodies, COMP level

EVENTS/KONFERENCJE

BOOKS/KSIĄŻKI

Original paperDynamics of anti-CCP antibodies and COMP level in sera of RA patients treated with leflunomide

Jakub Ząbek , Maria Rell-Bakalarska , Lidia Rutkowska-Sak , Janusz Jaworski , Bożena Wojciechowska

rheumatoid arthritis, leflunomid, anti-CCP antibodies, COMP level

Original paper
Dynamics of anti-CCP antibodies and COMP level in sera of RA patients treated with leflunomide

Jakub Ząbek

,

Maria Rell-Bakalarska

,

Lidia Rutkowska-Sak

,

Janusz Jaworski

,

Bożena Wojciechowska